Labshake search
Citations for R&D Systems :
101 - 150 of 690 citations for 4 4 Methylphenyl 1H pyrrole 3 carbonitrile since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: Recombinant 52-kDa pro-cath-D (4 µM; R&D Systems) was auto-activated to 51-kDa pseudo-cath-D in 0.1 M Na-acetate buffer (pH 3.5) ...
-
bioRxiv - Biochemistry 2022Quote: ... 20 ng/mL bone morphogenetic protein 4 (BMP4, R&D Systems), and 10 ng/mL fibroblast growth factor-basic (bFGF ...
-
bioRxiv - Cell Biology 2021Quote: ... 30 ng/ml Bone morphogenic protein-4 (BMP4) (R&D systems), 1.5 μM CHIR99021 (Stemgent) ...
-
bioRxiv - Microbiology 2020Quote: ... and 4,000 U/ml of rh IL-4 (R&D Systems) and cultured for 5 days ...
-
bioRxiv - Neuroscience 2022Quote: ... or IL-4 (20 ng/mL, 24 h, R&D Systems). Following stimulation ...
-
bioRxiv - Developmental Biology 2022Quote: ... BMP-4 (40 ng/ml, R&D Systems #5020-BP-010) or CHIR99021 (3 μM ...
-
bioRxiv - Cancer Biology 2022Quote: ... The caspase 4 inhibitor (Z-YVAD-FMK, FMK005, R&D systems) was used in further experiments at the dose of 50 µM ...
-
bioRxiv - Microbiology 2024Quote: ... and IL-4 (R&D Systems, Cat# 6507-IL-025/CF) in complete RPMI ...
-
bioRxiv - Immunology 2024Quote: ... TNFα and IL-4 using ELISA kits from R&D Systems in accordance with the manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... 4 µl of anti-V5-AF647 antibody (R&D Systems, FAB8926R) was used for staining cells for 20 minutes on a shaker at 500 rpm (Thermo Microplate Shaker) ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Immunology 2024Quote: ... 10 ng/mL of recombinant mouse IL-4 (R&D Systems) and 2 μg/mL of functional-grade purified anti-mouse CD40 (eBiosciences ...
-
bioRxiv - Cell Biology 2024Quote: ... and 21 ng/mL BMP-4 (R&D Systems, 5020-BP) for 3 days.
-
bioRxiv - Immunology 2021Quote: ... After washing wells were incubated with a 5-bromo-4-chloro-3⍰-indolyl phosphate (BCIP)/nitro blue tetrazolium (NBT) substrate (R&D systems, mouse IFNγ Kit Cat # EL485). Plates were scanned and analyzed using ImmunoSpot Microanalyzer.
-
bioRxiv - Neuroscience 2024Quote: ... cultures were cotreated with 20 nM (2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide dihydrochloride (LM11a-31)(R&D Systems, Minneapolis, MN, USA, Cat no: 5046) or vehicle solution consisting of DMSO during application of 6-OHDA ...
-
bioRxiv - Neuroscience 2021Quote: 10 ng/mL BMP-4 (R&D Systems cat. no. 314-BP)
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 404-ML, 10 ng/ml) in RPMI 1640 medium (Gibco cat ...
-
bioRxiv - Immunology 2020Quote: ... 25ng/ml IL-4 (404-ML-025, R&D Systems, Minneapolis MN) and 25ng/ml IL-21(210-21 ...
-
bioRxiv - Biochemistry 2021Quote: Four 4× stock solutions were prepared containing (i) Ube1 (R&D Systems) + UbcH5c/UBE2D3 (R&D Systems ...
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 204-IL, 35 ng/ml) in RPMI 1640 medium supplemented with 10% FBS and 2-Mercaptoethanol ...
-
bioRxiv - Cell Biology 2022Quote: ... and Laminin (R&D Systems #3446-005-01, 4-8 µg/cm2) coated glass-bottom Petri dishes (Greiner Bio-One #627975 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Th2 condition: Recombinant human IL-4 (10 ng/ml, R&D Systems), IL-5 (10 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... and stage-specific embryonic antigen-4 (SSEA4, R&D Systems, Minneapolis, USA) using immunocytochemistry (ICC) ...
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
bioRxiv - Immunology 2023Quote: ... Concentration of sCTLA-4 was estimated by ELISA (R&D Systems, DY476) or SDS-PAGE/CBB staining with bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2023Quote: ... or anti-toll-like receptor 4 (TLR4; clone #610029, R&D Systems). All antibodies were titrated using negative control cells that don’t or poorly express the target protein ...
-
CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing LossbioRxiv - Bioengineering 2023Quote: ... specimens were stained with anti-4 hydroxynonenal (R&D Systems MSB 3249) or anti 3-nitrotyrosine ...
-
bioRxiv - Immunology 2024Quote: ... 4) IL1B/IL1F2 DuoSet ELISA kits (R&D Systems, Minneapolis, MN, USA), following manufacturer’s protocols ...
-
bioRxiv - Cancer Biology 2024Quote: ... The ligands used were His-Tagged human Nectin-4 (R&D systems, catalog # 2659-N4-050 ...
-
bioRxiv - Immunology 2024Quote: ... anti- IL-4 and 2 ng/ml rhTGF-β1 (R&D Systems).
-
bioRxiv - Cell Biology 2024Quote: ... 4 µl of recombinant human VEGF (1 µg/µl, R&D Systems), or 4 µl of a solution containing both FITC-traC (0.75 µg/µl ...
-
bioRxiv - Cell Biology 2020Quote: ... and BMP4-Lif (10 ng/mL of mouse BMP-4 R&D Systems,Inc. ...
-
bioRxiv - Genomics 2020Quote: ... 4 μg normal rabbit IgG (R&D Systems, AB-105-C, lot: ER1212071) and ChIP-grade protein G magnetic beads (Cell Signalling 9006S ...
-
bioRxiv - Immunology 2022Quote: ... 30 μg/mL LPS plus 25 ng/mL IL-4 (R&D Systems); or 5 μg/mL LPS ...
-
bioRxiv - Cell Biology 2022Quote: ... and human bone morphogenetic protein 4 (hBMP4, 1.5 ng/ml; R&D Systems) together with human vascular endothelial growth factor (hVEGF ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Neuroscience 2020Quote: ... Antibodies used to assess pluripotency were anti-OCT3/4 (R&D Systems AF1759), anti-SOX2 (BD 245619) ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 ng/mL human bone morphogenetic protein 4 (Bmp4) (R&D Systems, Inc.), 20 ng/mL human basic fibroblast growth factor (b-FGF ...
-
bioRxiv - Cell Biology 2024Quote: ... 15 ng/mL BMP-4 (314-BP-050/CF; R&D Systems Inc) and 125 ng/mL Fibroblast growth factor (FGF ...
-
bioRxiv - Bioengineering 2023Quote: ... at 4°C for 16 h and measured via ELISA (R&D Systems). The distribution of TGF-β in Ø2×2 mm and Ø5×2 mm constructs was predicted via FE model (FEBio ...
-
bioRxiv - Immunology 2022Quote: ... or 4 μg/mL of anti-CCL1 Ab (clone 148113; R&D Systems), was added to the cultures.
-
bioRxiv - Immunology 2022Quote: ... 4 μg/mL of anti-CCL5 Ab (polyclonal goat IgG; R&D Systems), or 4 μg/mL of anti-CCL1 Ab (clone 148113 ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-4 (R&D systems, 402-ML-020)) ...
-
bioRxiv - Bioengineering 2023Quote: ... or 4 µg mL-1 human PDGFR beta antibody (AF385, R&D Systems) and 10 µg mL-1 human/mouse/rat alpha-smooth muscle actin antibody (MAB1420 ...
-
bioRxiv - Immunology 2023Quote: ... with 50 ng/ml of IL-4 (R&D systems, Minneapolis, MN, USA) and 50 ng/ml of GM-CSF (R&D Systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Cell Biology 2024Quote: ... Noggin 50ng/ml (day 0-4, 1967-NG-025/CF, R&D systems), DKK-1 10 ng/ml (day 0-6 ...
-
bioRxiv - Developmental Biology 2024Quote: ... 50 ng/mL bone morphogenic protein 4 (hBMP4, R&D Systems #314-BP), 10 ng/mL granulocyte colony-stimulating factor (hG-CSF ...
-
bioRxiv - Cell Biology 2024Quote: ... coated O/N at 4°C with 2% BME® (R&D systems) or 5 µg/ml recombinant Invasin protein ...